Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Once More Unto The Breach: 2014 NME Candidates Crowd In Familiar Fields

Feb 19 2014

• By Bridget Silverman

Related Content

PREVAIL Impresses, But Prostate Docs Wary Of Declaring Victory For <em>Xtandi</em> Over <em>Zytiga</em>

Feb 03 2014

More Me-Too Drugs Please, FDA’s Jenkins Asks Industry

Dec 12 2013

Related Companies

Express Scripts Holding Company

CVS Health Corp.

Merck & Co., Inc.

AstraZeneca PLC

Eli Lilly and Company

Bristol Myers Squibb Company

Boehringer Ingelheim GmbH

Pfizer Inc.

GSK plc

Sanofi

MannKind Corporation

Orexigen Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Arena Pharmaceuticals, Inc.

Vivus, Inc.

Amarin Corp plc

Regeneron Pharmaceuticals, Inc.

Amgen, Inc.

The Medicines Company

Octapharma AG

Novartis AG

Bristol Myers Squibb Company

Biogen, Inc.

Roche Holding AG

Gilead Sciences, Inc.

Medivation, Inc.

Johnson & Johnson

Pharmacyclics, Inc.

Additional Topics

Regulation Approvals BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window